Supporting your Patients

Articles and materials to support your patient’s needs

Nexviadyme ▼ (avalglucosidase alfa) website

Information for patients prescribed Nexviadyme

Fabry disease and self-care

  • Patient Support

Fabry disease and the 5-2-21 method

  • Patient Support

MPS I Physiotherapy Flipbook

ItsInYourMuscles

  • Patient Support

Introduce your patients to this muscle disease awareness site.

Resources and Tools

Explore tools and resources to help you with your daily work

Patient Organisation website

Discover more about the UK-based charity dedicated to raising awareness of Gaucher disease.

Cerdelga▼(eliglustat) Patient Materials

  • Patient Support

Access downloadable materials for patients who have been prescribed Cerdelga

MPS I Disease Awareness Slide Deck

This slide deck will support you in developing your knowledge of MPS I.

Diagnostic Algorithms for Gaucher disease

  • Patient Support

Learn more about the diagnostic algorithms for Gaucher disease.

Downloadable PDF: Signs & Symptoms of Gaucher disease

  • Patient Support

Learn more about the signs and symptoms of Gaucher disease.

Rare Diseases Products

ALDURAZYME
laronidase

Prescribing Information GB
Prescribing Information NI

 

MAT-XU-2200954 (v2.0)
Date of preparation: February 2023

CERDELGA
eliglustat 84mg

Prescribing Information GB
Prescribing Information NI

MAT-XU-2204064 (v2.0)
Date of preparation: January 2023

CEREZYME
imiglucerase

Prescribing Information GB
Prescribing Information NI

 

MAT-XU-2204065 (v2.0)
Date of preparation: January 2023

Fabrazyme
agalsidase beta

Prescribing Information GB
Prescribing Information NI

 

MAT-GB-2105812 (v4.0)
Date of preparation: May 2023

MYOZYME
alglucosidase alfa

Prescribing Information GB
Prescribing Information NI

MAT-GB-2105179 (v3.0)
Date of preparation: February 2023

NEXVIADYME
avalglucosidase alfa

Prescribing Information GB
GB ONLY CONTENT

 

MAT-XU-2203480 (v3.0)
Date of preparation: February 2023

Science of Rare Diseases

Learn about pathophysiology, testing and treatments, including specialised care services

Rare Diseases

MAT-XU-2203200(v1.0)
Date of preparation: September 2022